Insider Trade: Frank Jaksch Unloaded 474 Shares of ChromaDex (CDXC); Last Week Semtech (SMTC) Analysts

ChromaDex Corporation (NASDAQ:CDXC) Logo

Semtech Corporation (NASDAQ:SMTC) Ratings Coverage

Among 13 analysts covering Semtech (NASDAQ:SMTC), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Semtech had 38 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, November 30. The company was maintained on Thursday, November 30 by Drexel Hamilton. On Friday, August 14 the stock rating was upgraded by B. Riley & Co to “Sell”. The rating was maintained by Oppenheimer with “Market Perform” on Thursday, August 20. On Monday, July 3 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm has “Hold” rating by RBC Capital Markets given on Monday, October 2. RBC Capital Markets maintained it with “Hold” rating and $39.0 target in Wednesday, August 30 report. As per Wednesday, December 6, the company rating was maintained by Oppenheimer. The firm earned “Buy” rating on Wednesday, August 30 by Robert W. Baird. M Partners downgraded it to “Neutral” rating and $17 target in Friday, September 25 report. See Semtech Corporation (NASDAQ:SMTC) latest ratings:

23/03/2018 Broker: Needham Rating: Buy New Target: $45.0000 Maintain
15/03/2018 Broker: Roth Capital Rating: Buy New Target: $45.0 Maintain
15/03/2018 Broker: Needham Rating: Buy New Target: $45.0 Maintain
14/03/2018 Broker: Piper Jaffray Rating: Hold New Target: $40.0 Maintain
14/03/2018 Broker: Drexel Hamilton Rating: Buy New Target: $45.0 Maintain
18/01/2018 Broker: Needham Rating: Buy New Target: $42.0 Maintain
05/01/2018 Broker: Roth Capital Rating: Buy New Target: $39 Initiates Coverage On
19/12/2017 Broker: PiperJaffray Rating: Neutral New Target: $35 Initiates Coverage On
11/12/2017 Broker: Needham Rating: Buy New Target: $42.0 Initiate
06/12/2017 Broker: Oppenheimer Rating: Buy Maintain

The stock decreased 6.19% or $0.26 during the last trading session, reaching $3.94. About 473,433 shares traded. ChromaDex Corporation (NASDAQ:CDXC) has risen 63.20% since April 3, 2017 and is uptrending. It has outperformed by 51.65% the S&P500.

ChromaDex Corporation, a natural products company, discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies. The company has market cap of $216.05 million. The firm offers bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; Nicotinamide riboside , a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene (pTeroPure), a polyphenol and antioxidant used in health related fields; and Immulina, a spirulina extract and compound, which is used for improving human immune function, as well as developing Pterostilbene and caffeine co-crystal ingredients, and anthocyanins ingredients. It currently has negative earnings. It also provides reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications.

Analysts await ChromaDex Corporation (NASDAQ:CDXC) to report earnings on May, 10. They expect $-0.01 EPS, up 80.00% or $0.04 from last year’s $-0.05 per share. After $-0.17 actual EPS reported by ChromaDex Corporation for the previous quarter, Wall Street now forecasts -94.12% EPS growth.

Frank Jaksch; that is an insider in Chromadex Corp who is the most recent to sell shares in the company for which he is currently the CEO. He in the last few days sold 474 shares of the company, valued by the market at around $2,180 US Dollars, that is a price for each share of around $4.6. In the last month, he also unloaded 24,578 shares worth total $113,059 USD. This stock trade by Mr. Frank – was recorded on April 2, 2018 and made public in a SEC’s Form 4 available here. Currently, Mr. Frank, has ownership of 2.28 million shares, which accounts for 4.15% of Chromadex Corp’s market capitalization.

Since October 3, 2017, it had 0 insider buys, and 34 sales for $7.75 million activity. Pegulu Marc sold $38,214 worth of stock or 1,000 shares. KIM JAMES JUNGSUP had sold 1,500 shares worth $54,075. CHUKWU EMEKA had sold 2,000 shares worth $68,630. Another trade for 1,957 shares valued at $77,464 was made by Silberstein Asaf on Tuesday, October 10. Ammann Charles B. sold $83,250 worth of stock. On Thursday, March 15 the insider MAHESWARAN MOHAN sold $98,241. Brown Simon A sold $78,719 worth of Semtech Corporation (NASDAQ:SMTC) on Monday, March 19.

The stock decreased 3.07% or $1.2 during the last trading session, reaching $37.85. About 644,589 shares traded. Semtech Corporation (NASDAQ:SMTC) has risen 15.50% since April 2, 2017 and is uptrending. It has outperformed by 3.95% the S&P500.

Semtech Corporation (NASDAQ:SMTC) Institutional Positions Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: